This study compares the performance of automated breast ultrasonography and conventional hand-held whole breast ultrasonography when checking for response to breast cancer treatment. Breast ultrasonography is operator dependent and time-intensive. Automated breast ultrasonography scanners were developed to allow standardization of ultrasound scanning and scanning to be performed by any technologist, with or without previous ultrasound experience, without physician involvement. This study may validate the use of the automated breast ultrasonography.
PRIMARY OBJECTIVE: I. To estimate and compare the accuracy of automated breast ultrasonography (ABUS) and hand-held whole breast ultrasonography (WBUS) in predicting pathology complete response (pCR) with relative tumor volume change, using the receiver operating characteristic (ROC) curve analysis. SECONDARY OBJECTIVES: I. To evaluate the reproducibility of tumor volume measurements obtained by ABUS and handheld WBUS, respectively, using data collected at baseline for initial staging. II. To assess the agreement in relative tumor volume change (RC) (end-of-treatment versus \[vs.\] pre-treatment) between ABUS and WBUS. III. To estimate and compare the following diagnostic measures for ABUS and WBUS: sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV). OUTLINE: Patients undergo ABUS over 15 minutes followed by WBUS over 30 minutes at baseline, mid-treatment and pre-surgery (end of treatment).
Study Type
OBSERVATIONAL
Undergo ABUS
Undergo WBUS
M D Anderson Cancer Center
Houston, Texas, United States
Area under the receiver operating characteristic (ROC) curve
Will compute relative tumor volume change for both automated breast ultrasonography (ABUS) and hand-held whole breast ultrasonography (WBUS) and estimate pathology complete response ROC curves for each. Will estimate the areas under the ROC curves along with 95% confidence intervals and then compare the values statistically.
Time frame: through study completion, an average of 1 year
Tumor volume
Will compute the intraclass correlation coefficient for each method along with 95% confidence intervals and then compare these estimates.
Time frame: through study completion, an average of 1 year
Relative tumor volume change
Will compute the relative change in tumor volume for ABUS and WBUS and assess their agreement using the Bland-Altman approach.
Time frame: through study completion, an average of 1 year
Sensitivity
The cutoff point will be determined using Youden Index, i.e., the point that maximize (sensitivity specificity).
Time frame: through study completion, an average of 1 year
Specificity
The cutoff point will be determined using Youden Index, i.e., the point that maximize (sensitivity specificity).
Time frame: through study completion, an average of 1 year
Positive predictive value
Time frame: through study completion, an average of 1 year
Negative predictive value
Time frame: through study completion, an average of 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.